[1] Stancáková A, Baldaufová L, Javorský M, Kozárová M, Šalagovi?, J, Tká? I. Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of meta-bolic syndrome. Physiol Res, 2006, 55(5): 483–490.
[2] 黄爱群, 胡永华, 詹思延, 吕筠, 秦颖, 曹卫华, 李立明. 中国成年人双生子中脂蛋白酯酶基因多态性位点单体型与血脂关联分析. 中华流行病学杂志, 2007, 28(6): 523–527.
[3] 樊芸, 张蓉, 刘秉文, 张祖辉. 中国人内源性高甘油三酯血症与脂蛋白酯酶基因PvuⅡ多态性关联的研究. 中华医学遗传学杂志, 2001, 18(4): 296–298.
[4] 朱文丽, 齐智, 张震涛, 肖颖. 北京市西城区中老年人群脂蛋白脂酶基因多态性与高脂血症关系的研究. 中华医学遗传学杂志, 2002, 19(4): 361–362.
[5] 朱郇悯, 徐霞, 陈盛强. 脂蛋白脂酶PvuⅡ位点多态性与老年人群血脂的相关分析. 广州医学院学报, 2005, 33(3): 17–19, 31.
[6] 王坤, 敖由特, 武贵臻, 赵蕾, 郭艳英, 沙跟德克, 徐翀, 宋涛, 格尔莉, 何秉闲, 买苏木. 脂蛋白酯酶PvuⅡ和胆固醇酯转运蛋白TaqIB基因多态性与新疆哈萨克族高脂血症的关系. 中国医药导刊, 2006, 8(4): 255–258.
[7] 黄丽, 郭宏卫, 黄竹颖, 薛琨. 脂蛋白酯酶基因多态性与高脂血症和肥胖的膳食易感性研究. 营养学报, 2007, 29(3): 228–231.
[8] 崔晓栋, 张晓芸, 姜妙娜, 宋林莹, 葛光岩, 贾玉杰. 脂蛋白脂酶基因PvuⅡ酶切位点多态性与高脂血症的关系. 江西医药, 2008, 43(1): 16–19.
[9] Ye P, Pei L, Wang SW. Polymorphisms of the human lipo-protein lipase gene possible association with lipid levels in patients with coronary heart disease in Beijing area. Chin Med Sci J, 1996, 11(3): 157–161.
[10] 崔让庄, 毛用敏, 赵福梅, 陈倩, 赵燕行, 刘军, 殷雅琴. 脂蛋白酯酶基因多态性与冠心病和血脂水平的关系. 天津医药, 2000, 28(6): 343–346.
[11] 苏慧, 脂蛋白酯酶基因多态性与高脂血症及冠心病的关系研究(学位论文). 第四军医大学, 2001.
[12] 陈忠, 黄峻, 朱铁兵, 杨志健, 马根山, 曹克将. 早发冠心病128例患者脂蛋白脂酶基因多态性、酶活性及血脂关系的研究. 南京医科大学学报, 2002, 22(5): 370–372.
[13] 王胜煌, 崔翰斌, 王东琦, 崔长琮, 张福兴, 潘伟民, 储惠民, 王勇, 叶红华, 国阳. 中国汉族人群冠心病候选基因变异及其临床关联的地域特征. 中华心血管病杂志, 2008, 36(1): 24–29.
[14] Chamberlain JC, Thorn JA, Oka K. DNA polymorphisms at the lipoprotein lipase gene: association in normal and hypertriglyceridaemic subjects. Atherosclerosis, 1989, 79(1): 85–91.
[15] Wang XL, McCredie RM, Wilcken DE. Common DNA polymorphisms at the lipoprotein lipase gene: association with severity of coronary artery disease and diabetes. Circulation, 1996, 93(7): 1339–1345.
[16] Pašali? D, Serti? J, Kunovi? B, Pasi? A, Zrinski-Topi? R, Ferencak G, Stavljeni?-Rukavina A. Lipoprotein lipase gene polymorphism and lipid profile in patients with hy-pertriglyceridemia. Croat Med J, 2001, 42(5): 517–522.
[17] 杜纪坤, 黄青阳. 脂蛋白酯酶基因的研究进展. 遗传, 2007, 29(1): 8–16.
[18] 崔翰斌, 崔长琮, 马奕, 王东琦, 黄辰, 张爱峰, 廉姜芳, 苏显明. 高密度脂蛋白代谢相关基因单核苷酸多态性研究. 中华医学遗传学杂志, 2005, 22(1): 22–26.
[19] Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, Mixson L, Carlquist JF. Association of lipo-protein lipase gene polymorphisms with coronary artery disease. J Am Coll of Cardio, 1999, 33(4): 1013–1020.
[20] Abu-Amero KK, Wyngaard CA, Al-Boudari OM, Kam-bouris M, Dzimiri N. Lack of association of lipoprotein lipase gene polymorphisms with coronary artery disease in the Saudi Arab population. Arch Pathol Lab Med, 2003, 127(5): 597–600.
[21] Isbir T, Yilmaz H, Agachan B, Karaali ZE. Cholesterol ester transfer protein, apolipoprotein E and lipoprotein li-pase genotypes in patients with coronary artery disease in the Turkish population. Clin Genet, 2003, 64 (3): 228–234.
[22] Duman BS, Türko?lu C, Akpinar B, Güden M, Vertii A, Dak E, Ca?atay P, Günay D, Büyükdevrim AS. Lipopro-tein lipase gene polymorphism and lipid profile in coro-nary artery disease. Arch Pathol Lab Med, 2004, 128(8): 869–874.
[23] Régis-Bailly A, Visvikis S, Steinmetz J, Feldmann L, Bri-ancon S, Danchin N, Zannad F, Siest G. Frequencies of five genetic polymorphisms in coronarographed patients and effects on lipid levels in a supposedly healthy popula-tion. Clin Genet, 1996, 50 (5): 339–347.
[24] Cagatay P, Susleyici-Duman B, Ciftci C. Lipoprotein li-pase gene PvuII polymorphism serum lipids and risk for coronary artery disease: Meta-analysis. Dis Markers, 2007, 23(3): 161–166.
[25] Xie C, Wang ZC, Liu XF, Yang MS. |